Inovio Pharmaceuticals (INO) Q2 2026 Earnings

May 13Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.87
-0.67
-0.48
-0.28

Details

Expected EPS
-0.35
Actual EPS
-0.28
Surprise EPS
0.07
Surprise Percent
+20%

Description

⁨Inovio Pharmaceuticals⁩ (⁦INO⁩) has reported earnings of ⁦-0.28⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts